* BioSig Technologies Inc BSGM.OQ BSGM.O is expected
to show a
fall in quarterly revenue when it reports results on November
11 (estimated) for the period ending September 30 2024
*
* LSEG's mean analyst estimate for BioSig Technologies Inc
is for
a loss of 20 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for BioSig
Technologies Inc is 2.50, above its last closing price
of $1.99.
This summary was machine generated November 9 at 00:32 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)